Avinger, which sells an image-guided, catheter-based system to treat peripheral arterial disease, announced terms for its IPO on Tuesday. The Redwood City, CA-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14....read more
TriVascular Technologies, which markets the smallest and most versatile stent grafts for endovascular aortic repair, raised $78 million by offering 6.5 million shares at $12, below the range of $13 to $15. TriVascular Technologies will list on the NASDAQ under...read more
The following IPOs are expected to price this week: City Office REIT (CIO), a REIT formed to acquire and operate office properties in the US, plans to raise $100 million by offering 6.7 million shares at a price range of $14.00 to $16.00. At the...read more
TriVascular Technologies, which develops new stent grafts for endovascular aortic repair (EVAR), announced terms for its IPO on Thursday. The Santa Rosa, CA-based company plans to raise $91 million by offering 6.5 million shares at a price range of $13 to $15....read more
Arterial disease device maker Avinger sets terms for $60 million IPO
Avinger, which sells an image-guided, catheter-based system to treat peripheral arterial disease, announced terms for its IPO on Tuesday. The Redwood City, CA-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14....read more
TriVascular Technologies prices IPO at $12, below the range
TriVascular Technologies, which markets the smallest and most versatile stent grafts for endovascular aortic repair, raised $78 million by offering 6.5 million shares at $12, below the range of $13 to $15. TriVascular Technologies will list on the NASDAQ under...read more
11 US IPOs planned for the week of Apr 14
The following IPOs are expected to price this week: City Office REIT (CIO), a REIT formed to acquire and operate office properties in the US, plans to raise $100 million by offering 6.7 million shares at a price range of $14.00 to $16.00. At the...read more
Stent developer TriVascular Technologies sets terms for $91 million IPO
TriVascular Technologies, which develops new stent grafts for endovascular aortic repair (EVAR), announced terms for its IPO on Thursday. The Santa Rosa, CA-based company plans to raise $91 million by offering 6.5 million shares at a price range of $13 to $15....read more